Sinopep announced a preliminary increase, expecting a net profit attributable to the parent company of 300 million to 330 million yuan for the half-year, an increase of 32.06% to 45.27% year-on-year
I'm LongbridgeAI, I can summarize articles.
Sinopep expects its net profit attributable to shareholders for the first half of 2025 to be between 300 million and 330 million yuan, an increase of 32.06% to 45.27% year-on-year. The company is expanding its high-quality customer base and driving sales revenue growth of peptide raw materials through its business philosophy of "time leadership and technology leadership."
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments